Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 1
2023 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study.
Dingemans AM, van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, van den Berg CA, Kaasa S. Dingemans AM, et al. Among authors: soud my. Nutrients. 2023 Dec 7;15(24):5030. doi: 10.3390/nu15245030. Nutrients. 2023. PMID: 38140289 Free PMC article. Clinical Trial.
Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer.
Genet SAAM, Visser E, van den Borne BEEM, Soud MY, Belderbos HNA, Stege G, de Saegher MEA, Eduati F, Broeren MAC, van Dongen J, Brunsveld L, van de Kerkhof D, Scharnhorst V. Genet SAAM, et al. Among authors: soud my. Oncotarget. 2020 Jul 7;11(27):2660-2668. doi: 10.18632/oncotarget.27664. eCollection 2020 Jul 7. Oncotarget. 2020. PMID: 32676167 Free PMC article.
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial.
de Gooijer CJ, van der Noort V, Stigt JA, Baas P, Biesma B, Cornelissen R, van Walree N, van Heemst RC, Soud MY, Groen HJM, den Brekel AJS, Buikhuisen WA, Bootsma GP, Dammeijer F, van Tinteren H, Lalezari F, Aerts JG, Burgers JA; NVALT19 study group. de Gooijer CJ, et al. Among authors: soud my. Lancet Respir Med. 2021 Jun;9(6):585-592. doi: 10.1016/S2213-2600(20)30362-3. Epub 2021 Jan 27. Lancet Respir Med. 2021. PMID: 33515500 Clinical Trial.
Two-year survival and disease recurrence after endosonography with or without confirmatory mediastinoscopy for resectable lung cancer (a short communication of the MEDIASTrial follow-up).
Bousema JE, Spaans LN, Dijkgraaf MGW, van der Heijden EHFM, Verhagen AFTM, Annema JT, van den Broek FJC; MEDIASTrial study group. Bousema JE, et al. Lung Cancer. 2025 Apr;202:108462. doi: 10.1016/j.lungcan.2025.108462. Epub 2025 Mar 22. Lung Cancer. 2025. PMID: 40147400 Free article. Clinical Trial.